Bilde av Rasmussen Busund, Lill-Tove
Bilde av Rasmussen Busund, Lill-Tove
Institutt for medisinsk biologi lill.tove.rasmussen.busund@uit.no +47 41579210 Her finner du meg

Lill-Tove Rasmussen Busund


Professor/overlege i patologi

Stillingsbeskrivelse

Leder Translasjonell Kreftforskning IMB


  • Masoud Tafavvoghi, Lars Ailo Aslaksen Bongo, Nikita Shvetsov, Lill-Tove Rasmussen Busund, Kajsa Møllersen :
    Publicly available datasets of breast histopathology H&E whole-slide images: A scoping review
    Journal of Pathology Informatics 2024 DOI
  • Eiliv Lund, Lill-Tove Rasmussen Busund, Lars Holden :
    The curvilinear relationships between grand parity and incidence of hormone-dependent cancers; follow-up of postmenopausal women in the Norwegian 1960 Census
    medRxiv 2023 FULLTEKST / DOI
  • Hallgeir Selven, Lill-Tove Rasmussen Busund, Sigve Andersen, Mona Irene Pedersen, Ana Paola Lombardi, Thomas Karsten Kilvær :
    High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
    Cancers 2023 ARKIV / DOI
  • Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Ana Paola Lombardi, Mette Pøhl m.fl.:
    Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
    Frontiers in Oncology 2023 ARKIV / DOI
  • André Berli Delgado, Eline Sol Garthsdatter Tylden, Marko Lukic, Line Haugan Moi, Lill-Tove Rasmussen Busund, Eiliv Lund m.fl.:
    Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study
    PLOS ONE 2023 ARKIV / DOI
  • Mehrdad Rakaee, Sigve Andersen, K. Giannikou, Erna-Elise Paulsen, Thomas Karsten Kilvær, Lill-Tove Rasmussen Busund m.fl.:
    Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
    Annals of Oncology 2023 ARKIV / DOI
  • Hallgeir Selven, Sigve Andersen, Mona Irene Pedersen, Ana Paola Lombardi, Lill-Tove Rasmussen Busund, Thomas Karsten Kilvær :
    High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
    Scientific Reports 2022 ARKIV / DOI
  • Marta Tellez Gabriel, Xavier Tekpli, Trine M. Reine, Beate Hegge, Stephanie Rose Nielsen, Meng Chen m.fl.:
    Serglycin is Involved in TGF-β induced epithelial-mesenchymal transition and is highly expressed by immune cells in breast cancer tissue
    Frontiers in Oncology 14. april 2022 ARKIV / DOI
  • Nikita Shvetsov, Morten Grønnesby, Edvard Pedersen, Kajsa Møllersen, Lill-Tove Rasmussen Busund, Ruth Schwienbacher m.fl.:
    A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
    Cancers 2022 ARKIV / DOI
  • Maria Jenvin Støen, Sigve Andersen, Mehrdad Rakaee, Mona I. Pedersen, Lise Martine Ingebriktsen, Tom Dønnem m.fl.:
    Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
    Cancers 2021 ARKIV / DOI
  • Maria Jenvin Støen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Lise Martine Ingebriktsen, Roy M. Bremnes m.fl.:
    High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
    Scientific Reports 2021 ARKIV / DOI
  • Hallgeir Selven, Lill-Tove Rasmussen Busund, Sigve Andersen, Roy M. Bremnes, Thomas Karsten Kilvær :
    High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
    Scientific Reports 2021 ARKIV / DOI
  • Mehrdad Rakaee, Thomas Karsten Kilvær, Simin Jamaly, Thomas Berg, Erna-Elise Paulsen, Marte Berglund m.fl.:
    Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
    British Journal of Cancer 2021 DOI
  • Karina Standahl Olsen, Marit Holden, Jean-Christophe Thalabard, Lill-Tove Rasmussen Busund, Eiliv Lund, Lars Holden :
    Global blood gene expression profiles following a breast cancer diagnosis—Clinical follow-up in the NOWAC post-genome cohort
    PLOS ONE 2021 ARKIV / DOI
  • Mie Jareid, Igor Snapkov, Marit Holden, Lill-Tove Rasmussen Busund, Eiliv Lund, Therese Haugdahl Nøst :
    The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort
    PLOS ONE 2021 ARKIV / DOI
  • Lill-Tove Rasmussen Busund :
    Hypothesis of Carcinogenesis - The Atavistic Theory
    Universitetsforlaget 2020 DOI
  • Thomas Karsten Kilvær, Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, Roy M. Bremnes, Lill-Tove Rasmussen Busund m.fl.:
    Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
    Carcinogenesis 2020 ARKIV / DOI
  • Eiliv Lund, Marit Holden, Jean-Christophe Thalabard, Lill-Tove Rasmussen Busund, Igor Snapkov, Lars Holden :
    Signals of Death - Post-Diagnostic Single Gene Expression Trajectories in Breast Cancer - A Proof of Concept
    Universitetsforlaget 2020 ARKIV / DOI
  • Mehrdad Rakaee, Lill-Tove Busund, Simin Jamaly, Erna-Elise Paulsen, Elin Richardsen, Sigve Andersen m.fl.:
    Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
    Neoplasia 12. februar 2019 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Samer Al-Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen m.fl.:
    Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
    Scientific Reports 2019 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Christian Melbø-Jørgensen, Mehrdad Rakaee, Nora Ness, Samer Al-Saad m.fl.:
    MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
    Scientific Reports 2019 ARKIV / DOI
  • Thomas Karsten Kilvær, Mehrdad Rakaee, Turid Hellevik, Jørg Vik, Luigi de Petris, Tom Dønnem m.fl.:
    Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
    Scientific Reports 2019 ARKIV / DOI
  • Line Moi, Tonje Braaten, Khalid Al-Shibli, Eiliv Lund, Lill-Tove Rasmussen Busund :
    Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
    Journal of Translational Medicine 2019 ARKIV / DOI
  • Kaja Konstanse Skjefstad, Charles Johannessen, Thea K.W. Grindstad, Thomas Karsten Kilvær, Erna Elise Paulsen, Mona Irene Pedersen m.fl.:
    A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
    Scientific Reports 2018 ARKIV / DOI
  • Mehrdad Rakaee, Thomas Karsten Kilvær, Stig Manfred Dalen, Elin Richardsen, Erna Elise Paulsen, Sigurd Hald m.fl.:
    Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
    Human Pathology 2018 DOI
  • Eiliv Lund, Lill-Tove Busund, Jean-Christophe Thalabard :
    Rethinking the carcinogenesis of breast cancer: The theory of breast cancer as a child deficiency disease or a pseudo semi-allograft
    Medical Hypotheses 2018 ARKIV / DOI
  • Thomas Karsten Kilvær, Mehrdad Rakaee, Turid Hellevik, Arne Östman, Carina Strell, Roy M. Bremnes m.fl.:
    Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
    PLOS ONE 2018 ARKIV / DOI
  • Thea K.W. Grindstad, Elin Richardsen, Sigve Andersen, Kaja Konstanse Skjefstad, Mehrdad Rakaee, Tom Dønnem m.fl.:
    Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression
    Scientific Reports 2018 ARKIV / DOI
  • Sigurd Hald, Mehrdad Rakaee, Inigo Zubiavrre Martinez, Elin Richardsen, Samer Al-Saad, Erna Elise Paulsen m.fl.:
    LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
    Clinical Lung Cancer 2018 DOI
  • Yury Kiselev, Sigve Andersen, Charles Johannessen, Bjørn Fjukstad, Karina Standahl Olsen, Helge Stenvold m.fl.:
    Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
    Scientific Reports 2018 ARKIV / DOI
  • Nora Ness, Sigve Andersen, Mehrdad Rakaee, Cecilie Nordbakken, Andrey Yurjevich Valkov, Erna-Elise Paulsen m.fl.:
    The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
    OncoTarget 2017 ARKIV / DOI
  • Erna-Elise Paulsen, Thomas Karsten Kilvær, Mehrdad Rakaee, Elin Richardsen, Sigurd Hald, Sigve Andersen m.fl.:
    CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
    Cancer Immunology and Immunotherapy 2017 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Samer Al-Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen m.fl.:
    Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
    PLOS ONE 2017 ARKIV / DOI
  • Yngve Nordby, Elin Richardsen, Nora Ness, Tom Dønnem, Hitendra R.H. Patel, Lill-Tove Busund m.fl.:
    High miR-205 expression in normal epithelium is associated with biochemical failure - An argument for epithelial crosstalk in prostate cancer?
    Scientific Reports 2017 ARKIV / DOI
  • Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Helena Bertilsson, Roy M. Bremnes, Magne Børset m.fl.:
    Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer
    PLOS ONE 30. november 2017 ARKIV / DOI
  • Charles Johannessen, Line Moi, Yury Kiselev, Mona Irene Pedersen, Stig Manfred Dalen, Tonje Braaten m.fl.:
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
    PLOS ONE 2017 ARKIV / DOI
  • Åslaug Helland, Odd Terje Brustugun, Sigve Nakken, Ann Rita Halvorsen, Tom Dønnem, Roy M. Bremnes m.fl.:
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival
    International Journal of Cancer 2017 ARKIV / DOI
  • Eric J. Duell, Leila Lujan-Barroso, Núria Sala, Samantha Deitz McElyea, Kim Overvad, Anne Tjønneland m.fl.:
    Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study
    International Journal of Cancer 2017 ARKIV / DOI
  • Samer Al-Saad, Elin Richardsen, Thomas Karsten Kilvær, Tom Dønnem, Sigve Andersen, Mehrdad Rakaee m.fl.:
    The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
    PLOS ONE 2017 ARKIV / DOI
  • Yngve Nordby, Elin Richardsen, Mehrdad Rakaee, Nora Ness, Tom Dønnem, Hitendra R.H. Patel m.fl.:
    High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
    Scientific Reports 2017 ARKIV / DOI
  • Erna-Elise Paulsen, Thomas Karsten Kilvær, Mehrdad Rakaee, Samer Al-Saad, Sigurd Hald, Sigve Andersen m.fl.:
    Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
    Clinical Lung Cancer 2016 ARKIV / DOI
  • Tom Dønnem, Thomas Karsten Kilvær, Sigve Andersen, Elin Richardsen, Erna-Elise Paulsen, Sigurd Hald m.fl.:
    Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
    Annals of Oncology 2016 DOI
  • Mette Pøhl, Karen Ege Olsen, Rene Holst, Tom Dønnem, Lill-Tove Busund, Roy M. Bremnes m.fl.:
    Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer
    Acta Oncologica 2016 DOI
  • Sigve Andersen, Elin Richardsen, Line Moi, Tom Dønnem, Yngve Nordby, Nora Ness m.fl.:
    Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization)study
    Scientific Reports 2016 ARKIV / DOI
  • Roy M. Bremnes, Lill-Tove Busund, Thomas Karsten Kilvær, Sigve Andersen, Elin Richardsen, Erna-Elise Paulsen m.fl.:
    The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
    Journal of Thoracic Oncology 2016 DOI
  • Mehrdad Rakaee, Masoud Tafavvoghi, Elio Adib, Biagio Ricciuti, Joao Alessi, Alessio Cortellini m.fl.:
    Artificial intelligence algorithm developed to predict immune checkpoint inhibitors efficacy in non–small-cell lung cancer
    2023
  • Scheiner Bernhard, Alessio Antonio, Kim Gwangil, D. Goldin Robert, A.M. Fulgenzi Claudia, Balcar Lorenz m.fl.:
    MACHINE LEARNING-BASED ASSESSMENT OF TUMOUR- INFILTRATING LYMPHOCYTES PREDICTS OUTCOMES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING ATEZOLIZUMAB AND BEVACIZUMAB TREATMENT
    2023
  • Mehrdad Rakaee, Elio Adib, Biagio Ricciuti, Lynette M. Sholl, Joao V.Alessi, Alessio Cortellini m.fl.:
    Digital quantification of lymphocytic infiltration on routine H&E images and immunotherapy response in non-small cell lung cancer
    2022
  • Kaja Konstanse Skjefstad, Thea K.W. Grindstad, Mehrdad Rakaee, Elin Richardsen, Tom Dønnem, Thomas Karsten Kilvær m.fl.:
    Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
    Steroids 2018 DOI
  • Roy M. Bremnes, Tom Dønnem, Lill-Tove Busund :
    Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?
    Annals of Translational Medicine 2016 DOI

  • De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →


    Forskningsinteresser

    Biomarkører i kreftsvulster og blod som kan gi informasjon om framtidig kreftsykdom, hvilken type kreftsykdom, prognose av kreftsykdom og hvilken behandling som kan gi effekt. 

    Undervisning

    Leder Delemne 2.4 Bevegelse i Profesjonsstudiet Medisin





    Vedlegg: